Genetic Technologies (NASDAQ: GENE)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Genetic Technologies (NASDAQ: GENE) through any online brokerage.
Other companies in Genetic Technologies’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codex DNA (NASDAQ:DNAY), IsoPlexis (NASDAQ:ISO), Personalis (NASDAQ:PSNL) and Quoin Pharmaceuticals (NASDAQ:QNRX).
The latest price target for Genetic Technologies (NASDAQ: GENE) was reported by Ladenburg Thalmann on Friday, November 16, 2012. The analyst firm set a price target for 0.00 expecting GENE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Genetic Technologies (NASDAQ: GENE) is $1.5691 last updated August 24, 2022, 7:55 PM UTC.
There are no upcoming dividends for Genetic Technologies.
Genetic Technologies does not have any upcoming earnings scheduled.
There is no upcoming split for Genetic Technologies.
Genetic Technologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.